Encompass Health Management
Management criteria checks 4/4
Encompass Health's CEO is Mark Tarr, appointed in Dec 2016, has a tenure of 8.5 years. total yearly compensation is $9.30M, comprised of 11.3% salary and 88.7% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth $64.04M. The average tenure of the management team and the board of directors is 9.9 years and 5.4 years respectively.
Key information
Mark Tarr
Chief executive officer
US$9.3m
Total compensation
| CEO salary percentage | 11.29% |
| CEO tenure | 8.5yrs |
| CEO ownership | 0.5% |
| Management average tenure | 9.9yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Here's Why We Think Encompass Health (NYSE:EHC) Is Well Worth Watching
May 21
Here's Why Encompass Health Corporation's (NYSE:EHC) CEO May Deserve A Raise
Apr 25We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Mar 19What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?
Feb 13Earnings Not Telling The Story For Encompass Health Corporation (NYSE:EHC)
Jan 29Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors
Dec 10Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings
Oct 21Is Encompass Health (NYSE:EHC) Using Too Much Debt?
Oct 03Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27
Expanding Healthcare Services And Decisive Partnerships Propel Revenue Growth And Shareholder Value
Expanding service demand through significant growth in neurological and stroke treatment areas suggests potential for future revenue increases.Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health declares $0.15 dividend
Feb 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | US$494m |
| Dec 31 2024 | US$9m | US$1m | US$456m |
| Sep 30 2024 | n/a | n/a | US$431m |
| Jun 30 2024 | n/a | n/a | US$409m |
| Mar 31 2024 | n/a | n/a | US$387m |
| Dec 31 2023 | US$9m | US$1m | US$362m |
| Sep 30 2023 | n/a | n/a | US$357m |
| Jun 30 2023 | n/a | n/a | US$336m |
| Mar 31 2023 | n/a | n/a | US$280m |
| Dec 31 2022 | US$8m | US$1m | US$256m |
| Sep 30 2022 | n/a | n/a | US$232m |
| Jun 30 2022 | n/a | n/a | US$242m |
| Mar 31 2022 | n/a | n/a | US$253m |
| Dec 31 2021 | US$8m | US$1m | US$298m |
| Sep 30 2021 | n/a | n/a | US$316m |
| Jun 30 2021 | n/a | n/a | US$318m |
| Mar 31 2021 | n/a | n/a | US$304m |
| Dec 31 2020 | US$7m | US$953k | US$193m |
| Sep 30 2020 | n/a | n/a | US$265m |
| Jun 30 2020 | n/a | n/a | US$285m |
| Mar 31 2020 | n/a | n/a | US$342m |
| Dec 31 2019 | US$7m | US$1m | US$358m |
| Sep 30 2019 | n/a | n/a | US$317m |
| Jun 30 2019 | n/a | n/a | US$308m |
| Mar 31 2019 | n/a | n/a | US$309m |
| Dec 31 2018 | US$6m | US$963k | US$290m |
Compensation vs Market: Mark's total compensation ($USD9.30M) is below average for companies of similar size in the US market ($USD14.19M).
Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.
CEO
Mark Tarr (63 yo)
Mr. Mark J. Tarr is Director of Children's of Alabama. Mr. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encom...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.5yrs | US$9.30m | 0.52% $ 64.0m | |
| Executive VP & CFO | 15.1yrs | US$3.87m | 0.25% $ 30.5m | |
| Senior VP & Chief Accounting Officer | 15.7yrs | US$1.07m | 0.069% $ 8.5m | |
| Executive VP | 9.3yrs | US$2.56m | 0.079% $ 9.7m | |
| Chief Medical Officer | 9.9yrs | US$1.29m | 0.012% $ 1.5m | |
| EVP & Chief Operating Officer | less than a year | no data | 0.020% $ 2.4m | |
| Chief Information Officer & Senior VP | 13.9yrs | no data | no data | |
| Senior Vice President of Investor Relations & Strategic Planning | 3.8yrs | no data | no data | |
| Chief Compliance Officer | 9.9yrs | no data | no data | |
| Chief Human Resources Officer | 5.4yrs | no data | no data | |
| President of Southwest Region | 13.8yrs | no data | no data | |
| President of West Region | 13.8yrs | no data | no data |
Experienced Management: EHC's management team is seasoned and experienced (9.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.5yrs | US$9.30m | 0.52% $ 64.0m | |
| Independent Director | 12.4yrs | US$303.88k | 0.00099% $ 121.3k | |
| Independent Director | 12.4yrs | US$318.85k | 0.00099% $ 121.3k | |
| Independent Director | 7.5yrs | US$296.49k | 0.00013% $ 15.9k | |
| Independent Chairman | 5.4yrs | US$385.68k | 0.0038% $ 465.4k | |
| Independent Director | 5.4yrs | US$292.55k | 0.000020% $ 2.4k | |
| Independent Director | 3.7yrs | US$306.41k | 0.014% $ 1.8m | |
| Independent Director | 1.6yrs | US$272.91k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$275.64k | 0.0010% $ 122.5k | |
| Independent Director | 5.4yrs | US$284.28k | 0.00035% $ 42.9k |
Experienced Board: EHC's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/04 14:12 |
| End of Day Share Price | 2025/06/04 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Encompass Health Corporation is covered by 35 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null RESEARCH DEPARTMENT | Avondale Partners |
| Matthew Gillmor | Baird |
| Ishan Majumdar | Baptista Research |